Rabbit Recombinant Monoclonal MAT1A antibody. Carrier free. Suitable for ICC/IF, WB, Flow Cyt (Intra) and reacts with Human, Mouse, Rat, Recombinant full length protein - Human samples.
pH: 7.2 - 7.4
Constituents: PBS
ICC/IF | WB | Flow Cyt (Intra) | |
---|---|---|---|
Human | Tested | Tested | Tested |
Mouse | Expected | Tested | Expected |
Rat | Expected | Tested | Expected |
Recombinant full length protein - Human | Not recommended | Tested | Not recommended |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Recombinant full length protein - Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat, Recombinant full length protein - Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Recombinant full length protein - Human | Dilution info - | Notes - |
Select an associated product type
Catalyzes the formation of S-adenosylmethionine from methionine and ATP. The reaction comprises two steps that are both catalyzed by the same enzyme: formation of S-adenosylmethionine (AdoMet) and triphosphate, and subsequent hydrolysis of the triphosphate.
MAT2A
AMS1, MATA1, MAT1A, S-adenosylmethionine synthase isoform type-1, AdoMet synthase 1, Methionine adenosyltransferase 1, Methionine adenosyltransferase I/III, MAT 1, MAT-I/III
Rabbit Recombinant Monoclonal MAT1A antibody. Carrier free. Suitable for ICC/IF, WB, Flow Cyt (Intra) and reacts with Human, Mouse, Rat, Recombinant full length protein - Human samples.
pH: 7.2 - 7.4
Constituents: PBS
ab249988 is the carrier-free version of Anti-MAT2A + MAT1A antibody [EPR10496] ab177484.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. The carrier-free buffer and high concentration allow for increased conjugation efficiency.
This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
MAT2A (methionine adenosyltransferase 2A) and MAT1A (methionine adenosyltransferase 1A) are enzymes that catalyze the formation of S-adenosylmethionine (SAM) from methionine and ATP. MAT2A has a mass of approximately 43 kDa while MAT1A is around 45 kDa. MAT2A is expressed in all tissues except the liver where MAT1A is the more common form. The liver abundantly expresses MAT1A positioning it as a major contributor to hepatic SAM production while MAT2A forms are often seen in peripheral tissues and in proliferating cells.
MAT2A and MAT1A play roles in one-carbon metabolism and are essential for the synthesis of SAM a universal methyl donor involved in methylation reactions. As part of a catalytic complex these enzymes contribute to the regulation of cellular methylation status and impact polyamine synthesis antioxidant defense and nucleotide synthesis. The activities of MAT2A and MAT1A influence cellular growth and differentiation reflecting their significance in metabolism and gene expression regulation.
MAT2A and MAT1A participate in the methionine cycle which intersects with the folate cycle to regulate methylation processes and homocysteine levels. They form part of the trans-sulfuration and transmethylation pathways essential for converting methionine to cysteine and for methyl group transfers. Their activities align with pathways involving methionine synthase which similarly contributes to methyl group transfer and cycling of methionine and folates.
Dysfunction in MAT2A and MAT1A associates with liver diseases and certain cancers. In liver disorders imbalance in SAM synthesis due to MAT1A deficiencies can lead to hepatic steatosis and fibrosis. In cancer upregulation of MAT2A supports tumor growth by providing SAM for enhanced methylation and proliferation of cancer cells. Related proteins like glycine N-methyltransferase also connect to these disorders through their roles in SAM metabolism and regulation.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
This data was developed using Anti-MAT2A + MAT1A antibody [EPR10496] ab177484, the same antibody clone in a different buffer formulation.
MAT1A: 44kDa ; MAT2A: 46kDa
Blocking Buffer and concentration: 5% NFDM/TBST
All lanes: Western blot - Anti-MAT2A + MAT1A antibody [EPR10496] (Anti-MAT2A + MAT1A antibody [EPR10496] ab177484) at 1/1000 dilution
Lane 1: HeLa (Human cervix adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2: HepG2 (Human hepatocellular carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 3: Ramos (Human Burkitt's lymphoma B lymphocyte) whole cell lysate at 20 µg
Lane 4: 293T (Human embryonic kidney epithelial cell) whole cell lysate at 20 µg
Lane 5: NIH/3T3 (Mouse embryonic fibroblast) whole cell lysate at 20 µg
Lane 6: C6 (Rat glial tumor glial cell) whole cell lysate at 20 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Predicted band size: 44 kDa
Observed band size: 44 kDa, 46 kDa
This data was developed using Anti-MAT2A + MAT1A antibody [EPR10496] ab177484, the same antibody clone in a different buffer formulation.
Immunocytochemistry analysis of HeLa (Human cervix adenocarcinoma epithelial cell) cells labeling MAT2A+MAT1A with Purified ab249988 at 1:100 dilution (2.52 ?g/ml). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with Alexa Fluor® 594 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1:200 (2.5 μg/ml). Goat anti rabbit IgG (Alexa Fluor® 488, Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) ab150077) was used as the secondary antibody at 1:1000 (2 μg/ml) dilution. DAPI (blue) was used as nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.
This data was developed using Anti-MAT2A + MAT1A antibody [EPR10496] ab177484, the same antibody clone in a different buffer formulation.Intracellular Flow Cytometry analysis of Ramos (Human Burkitt's lymphoma B lymphocyte) cells labeling MAT2A+MAT1A with Purified ab249988 at 1/30 dilution (10μg/ml) (Red). Cells were fixed with 4% Paraformaldehyde and permeabilised with 90% Methanol. A Goat anti rabbit IgG (Alexa Fluor® 488, Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) ab150077) secondary antibody was used at 1/2000. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).
This data was developed using Anti-MAT2A + MAT1A antibody [EPR10496] ab177484, the same antibody clone in a different buffer formulation.Intracellular Flow Cytometry analysis of HeLa (Human cervix adenocarcinoma epithelial cell) cells labeling MAT2A+MAT1A with Purified ab249988 at 1/30 dilution (10μg/ml) (Red). Cells were fixed with 4% Paraformaldehyde and permeabilised with 90% Methanol. A Goat anti rabbit IgG (Alexa Fluor® 488, Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) ab150077) secondary antibody was used at 1/2000. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).
This data was developed using Anti-MAT2A + MAT1A antibody [EPR10496] ab177484, the same antibody clone in a different buffer formulation.
MAT1A: Full-length recombinant protein (aa1-395) with His-Tag was made in-house.
MAT2A: Full-length recombinant protein (aa1-364) with GST-Tag was from Abnova company.
Blocking and dilution buffer: 5% NFDM/TBST.
Exposure time: Lane 1: 1 second. Lane 2: 3 seconds.
All lanes: Western blot - Anti-MAT2A + MAT1A antibody [EPR10496] (Anti-MAT2A + MAT1A antibody [EPR10496] ab177484) at 1/10000 dilution
Lane 1: Full-length Human MAT1A recombinant protein with His-Tag at 0.015 µg
Lane 2: Full-length Human MAT2A recombinant protein with GST-Tag at 0.015 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) (Goat Anti-Rabbit IgG H&L (HRP) ab97051) at 1/20000 dilution
Predicted band size: 44 kDa
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com